Tilray Inc (NASDAQ:TLRY - Get Free Report)'s stock price traded down 0.2% during trading on Wednesday . The company traded as low as $0.44 and last traded at $0.45. 12,721,637 shares traded hands during mid-day trading, a decline of 55% from the average session volume of 28,082,218 shares. The stock had previously closed at $0.45.
Analyst Upgrades and Downgrades
TLRY has been the subject of a number of recent analyst reports. Roth Capital reaffirmed a "neutral" rating on shares of Tilray in a research note on Monday, April 14th. Piper Sandler dropped their price target on shares of Tilray from $2.00 to $1.00 and set a "neutral" rating for the company in a research note on Wednesday, April 9th.
Check Out Our Latest Analysis on TLRY
Tilray Stock Performance
The stock has a market capitalization of $445.27 million, a PE ratio of -1.47 and a beta of 1.95. The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10. The business's 50 day moving average is $0.52 and its 200 day moving average is $0.92.
Tilray (NASDAQ:TLRY - Get Free Report) last released its quarterly earnings data on Tuesday, April 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($0.06). The company had revenue of $185.78 million during the quarter, compared to analysts' expectations of $213.38 million. Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. On average, equities research analysts predict that Tilray Inc will post -0.2 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Tilray
Large investors have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP boosted its position in Tilray by 54.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,172,935 shares of the company's stock valued at $2,890,000 after buying an additional 769,569 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of Tilray by 112.7% in the 4th quarter. JPMorgan Chase & Co. now owns 919,082 shares of the company's stock valued at $1,222,000 after purchasing an additional 487,051 shares in the last quarter. Raymond James Financial Inc. bought a new stake in shares of Tilray in the 4th quarter valued at about $255,000. Atria Wealth Solutions Inc. raised its holdings in shares of Tilray by 174.7% in the 4th quarter. Atria Wealth Solutions Inc. now owns 84,516 shares of the company's stock valued at $112,000 after purchasing an additional 53,751 shares in the last quarter. Finally, Tidal Investments LLC raised its holdings in shares of Tilray by 9.2% in the 4th quarter. Tidal Investments LLC now owns 10,595,264 shares of the company's stock valued at $14,092,000 after purchasing an additional 889,086 shares in the last quarter. 9.35% of the stock is owned by hedge funds and other institutional investors.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
See Also
Before you consider Tilray Brands, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.
While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
